RecruitingNCT05638841

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation


Sponsor

Peking University Third Hospital

Enrollment

300 participants

Start Date

Jan 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • \) Age \> 18
  • \) ECG or holter electrocardiogram confirmed atrial fibrillation

Exclusion Criteria5

  • \) Hematological diseases, autoimmune diseases and malignant tumors
  • \) Immobility caused by hemiplegia or severe trauma
  • \) The expected survival time is less than 2 years
  • \) Poor compliance and high risk of expected loss of follow-up
  • \) Disorders of consciousness or Alzheimer's disease

Interventions

OTHERAfter radiofrequency ablation of atrial fibrillation

This study imposed an intervention. Clinical data were obtained by telephone or outpatient follow-up.


Locations(1)

Peking-University-Third-Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05638841


Related Trials